GLA-AF adjuvant: Clinical Trials

5 trials of GLA-AF adjuvant, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 15Completed 5

Follow GLA-AF adjuvant: new trials by email Literature Review of GLA-AF adjuvant trials Research Report on GLA-AF adjuvant

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase Ib Study of the Safety, Reactogenicity, and Immunogenicity of Sm-TSP-2/Alhydrogel)(R) With or Without AP 10-701 for Intestinal Schistosomiasis in Healthy Exposed Adults
GLA-AF, Hepatitis B Virus Vaccine (Recombinant), Sm-TSP-2/Alhydrogel - Schistosomiasis
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)602018-05-202021-02-02
Safety and Immunogenicity of the Na-APR-1 Hookworm Vaccine in Healthy Adults
Na-APR-1 (M74)/Alhydrogel®, Gluco-Pyranosylphospho-Lipid A Aqueous Formulation - Hookworm Infection, Hookworm Disease
Phase 1CompletedBaylor College of Medicine402013-09-012019-07-31
Investigating Immunisation Strategies of DNA, MVA and CN54rgp140 Adjuvanted With GLA-AF to Maximise Antibody Responses
DNA, MVA-C, CN54rgp140 - HIV
Phase 1CompletedImperial College London402013-06-012016-09-27
The Effects of GLA (5 mcg) on Human Volunteers
GLA-AF, GLA-SE, EM060G (SE) - Healthy Volunteers
Phase 1CompletedAccess to Advanced Health Institute (AAHI)172012-09-012014-02-26
The Effects of GLA on Human Volunteers
GLA-AF, GLA-SE, Squalene - Healthy Volunteers
Phase 1CompletedRockefeller University322011-07-012013-09-23

Conditions studied

Ancylostomiasis (1)  ·  Anemia, Iron-Deficiency (1)  ·  Hookworm Infections (1)  ·  Neglected Diseases (1)  ·  Schistosomiasis (1)

Sponsors

Access to Advanced Health Institute (AAHI) (1)  ·  Baylor College of Medicine (1)  ·  Imperial College London (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  Rockefeller University (1)

Countries

United States (3)  ·  Brazil (1)  ·  United Kingdom (1)

Top investigators

David J Diemert, MD (1)  ·  Franco Piazza, MD, MPH (1)  ·  Marina Caskey, MD (1)  ·  Sheena McCormack, MSc, FRCP (1)

Results publications

PMID 36996185